BioMarin Pharmaceutical Inc. reaffirmed earnings guidance for the year 2024. For the year, the company expects there is no change in total revenues.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
77.56 USD | +0.77% | -4.28% | -19.56% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.56% | 14.73B | |
-2.32% | 90.45B | |
+3.68% | 41.45B | |
-10.90% | 33.57B | |
+58.05% | 25.73B | |
-9.06% | 12.82B | |
-11.34% | 11.7B | |
-43.53% | 11.44B | |
+3.75% | 8.79B | |
-6.32% | 8.35B |
- Stock Market
- Equities
- BMRN Stock
- News BioMarin Pharmaceutical Inc.
- Biomarin Pharmaceutical Inc. Reaffirms Earnings Guidance for the Year 2024